Top

Clinical Rheumatology

Published in:

01-03-2021 | Ehlers-Danlos Syndrome | Original Article

The effectiveness of conservative interventions for the management of syndromic hypermobility: a systematic literature review

Authors: Shea Palmer, Indi Davey, Laura Oliver, Amara Preece, Laura Sowerby, Sophie House

Published in: Clinical Rheumatology | Issue 3/2021

Abstract

Introduction

‘Syndromic hypermobility’ encompasses heritable connective tissue disorders such as hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorders which are characterised by excessive joint range of motion and pain. Conservative interventions such as exercise are the cornerstone of management, yet their effectiveness is unclear.

Aim

To systematically appraise the effectiveness of conservative management for people with syndromic hypermobility.

Method

A systematic online database search was conducted (AMED, BND, CINAHL Plus, MEDLINE, PEDro, PsychINFO and SportDiscus). Potential articles were assessed for eligibility by two researchers against the following criteria: adults and children with a hEDS/HSD diagnosis (or equivalent diagnosis using specific criteria); non-pharmacological or non-surgical interventions; outcomes related to pain, physical function, psychological well-being or quality of life. Controlled trials and cohort studies were included. Critical Appraisal Skills Programme checklists were used to assess methodological quality.

Results

Eleven studies were included, comprising eight controlled trials and three cohort studies. All studies investigated interventions that had exercise as the primary component. Three small controlled studies demonstrated superior effects of conservative management relative to a control group. However, those studies only focused on a single area of the body, only recruited women, and had no long-term follow-up. All studies reported improvements in a wide range of outcomes over time.

Conclusion

Controlled trial evidence for the superiority of conservative management over comparators is weak. There is some evidence that people improve over time. Robust randomised controlled trial research of the long-term effectiveness of ‘whole-body’ (rather than individual joints or body areas) conservative management is required.

Key Points

• Conservative management is the cornerstone of management of syndromic hypermobility.

• The review found that evidence for the effectiveness of conservative management relative to no treatment or other conservative comparators was weak.

• However, there was consistent evidence for effectiveness from pre- to post-treatment.

• Further robust randomised controlled trial evidence is required.

Castori M, Tinkle B, Levy H, Grahame R, Malfait F, Hakim A (2017) A framework for the classification of joint hypermobility syndrome and related conditions. Am J Med Genet C: Semin Med Genet 175(1):148–157. https://doi.org/10.1002/ajmg.c.31539CrossRef

Malfait F, Francomano C, Byers P, Belmont J, Berglund B, Black J, Bloom L, Bowen JM, Brady AF, Burrows NP, Castori M, Cohen H, Colombi M, Demirdas S, De Backer J, De Paepe A, Fournel-Gigleux S, Frank M, Ghali N, Giunta C, Grahame R, Hakim A, Jeunemaitre X, Johnson D, Juul-Kristensen B, Kapferer-Seebacher I, Kazkaz H, Kosho T, Lavallee ME, Levy H, Mendoza-Londono R, Pepin M, Pope FM, Reinstein E, Robert L, Rohrbach M, Sanders L, Sobey GJ, Van Damme T, Vandersteen A, van Mourik C, Voermans N, Wheeldon N, Zschocke J, Tinkle B (2017) The 2017 international classification of the Ehlers-Danlos syndromes. AmJ Med Genet C: Semin Med Genet 175(1):8–26. https://doi.org/10.1002/ajmg.c.31552CrossRef

Beighton P, De Paepe A, Steinmann B, Tsipouras P, Wenstrup RJ (1998) Ehlers-Danlos syndromes: revised nosology, Villefranche, 1997. Am J Med Genet 77:31–37. https://doi.org/10.1002/(sici)1096-8628(19980428)77:1<31::aid-ajmg8>3.0.co;2-oCrossRefPubMed

Grahame R, Bird HA, Child A (2000) The revised (Brighton 1998) criteria for the diagnosis of benign joint hypermobility syndrome (BJHS). J Rheumatol 27(7):1777–1779PubMed

Terry R, Palmer S, Rimes K, Clark C, Simmonds J, Horwood J (2015) Living with joint hypermobility syndrome. Patient experiences of diagnosis, referral and self-care. Fam Pract 32(3):354–358. https://doi.org/10.1093/fampra/cmv026CrossRefPubMedPubMedCentral

Tinkle B, Castori M, Berglund B, Cohen H, Grahame R, Kazkaz H, Levy H (2017) Hypermobile Ehlers-Danlos syndrome (a.k.a. Ehlers-Danlos syndrome type III and Ehlers-Danlos syndrome hypermobility type): clinical description and natural history. Am J Med Genet Part C Semin Med Genet 175C:48–69. https://doi.org/10.1002/ajmg.c.31538CrossRef

Palmer S, Cramp F, Lewis R, Muhammad S, Clark E (2015) Diagnosis, management and assessment of adults with joint hypermobility syndrome: a UK wide survey of physiotherapy practice. Musculoskeletal Care 13:101–111. https://doi.org/10.1002/msc.1091CrossRefPubMed

Connelly E, Hakim E, Davenport S, Simmonds J (2014) A study exploring the prevalence of joint hypermobility syndrome in patients attending a musculoskeletal triage clinic. Physiother Pract Res 36(1):43–53. https://doi.org/10.3233/PPR-140046CrossRef

To M, Simmonds J, Alexander C (2017) Where do people with joint hypermobility syndrome present in secondary care? The prevalence in a general hospital and the challenges of classification. Musculoskeletal Care 15(1:3–9. https://doi.org/10.1002/msc.1147CrossRef

10.

Simmonds J, Keer R (2008) Hypermobility and the hypermobility syndrome, part 2: assessment and management of hypermobility syndrome. Man Ther 13(2):1–11. https://doi.org/10.1016/j.math.2007.11.001CrossRef

11.

British Society for Paediatric and Adolescent Rheumatology (BSPAR) (2012) Guidelines for management of joint hypermobility syndrome in children and young people. Available from: https://www.sparn.scot.nhs.uk/wp-content/uploads/2017/01/Guidelines-for-Management-of-Joint-Hypermobility-Syndrome-v1.1-June-2013.pdf [Accessed 13 March 2020]

12.

Hashemi-Nejad A, Vanhegan I (2016) Ehlers-Danlos support UK - orthopaedic surgery in hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorders. Available from: https://www.ehlers-danlos.org/information/orthopaedic-surgery-in-hypermobile-ehlers-danlos-syndrome-and-hypermobility-spectrum-disorders [Accessed 13 March 2020]

13.

Rombaut L, Malfait F, de Wandele I, Cools A, Thijs Y, de Paepe A, Calders P (2011) Medication, surgery, and physiotherapy among patients with the hypermobility type of Ehlers-Danlos syndrome. Arch Phys Med Rehabil 92(7):1106–1112. https://doi.org/10.1016/j.apmr.2011.01.016CrossRefPubMed

14.

Smith T, Bacon H, Jerman E, Easton V, Armon K, Poland F, Macgregor AJ (2014) Physiotherapy and occupational therapy interventions for people with benign joint hypermobility syndrome: a systematic review of clinical trials. Disabil Rehabil 36(10):797–803. https://doi.org/10.3109/09638288.2013.819388CrossRefPubMed

15.

Palmer S, Bailey S, Barker L, Barney L, Elliott A (2014) The effectiveness of therapeutic exercise for joint hypermobility syndrome: a systematic review. Physiotherapy 100:220–227. https://doi.org/10.1016/j.physio.2013.09.002CrossRefPubMed

16.

Peterson B, Coda A, Pacey V, Hawke F (2018) Physical and mechanical therapies for lower limb symptoms in children with hypermobility spectrum disorder and hypermobile Ehlers-Danlos syndrome: a systematic review. J Foot Ankle Res 11(1):1–11. https://doi.org/10.1186/s13047-018-0302-1CrossRef

17.

Sulli A, Talarico R, Scire CA, Avcin T, Castori M, Ferraris A, Frank C, Grunert J, Paolino S, Bombardieri S, Schneider M, Smith V, Cutolo M, Mosca M, Malfait F (2018) Ehlers-Danlos syndromes: state of the art on clinical practice guidelines. RMD Open 4(S1):e000790. https://doi.org/10.1136/2Frmdopen-2018-000790

18.

Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group (2009) Preferred reporting items for systematic reviews and metaanalyses: the PRISMA statement. PLoS Med 6(7):e1000097. https://doi.org/10.1371/journal.pmed.1000097CrossRefPubMedPubMedCentral

19.

Methley A, Campbell S, Chew-Graham C, McNally R, Cheraghi-Sohi S (2014) PICO, PICOS and SPIDER: a comprehensive study of the specificity and sensitivity in three search tools for qualitative systematic reviews. BMC Health Serv Res 14(579):1–10. https://doi.org/10.1186/s12913-014-0579-0CrossRef

20.

Ecker E, Skelly A (2010) Conducting a winning literature search. Evid Based Spine Care J 1(1):9–14. https://doi.org/10.1055/2Fs-0028-1100887CrossRefPubMedPubMedCentral

21.

Marnach M, Ramin K, Ramsey P, Song S, Stensland J, An K (2003) Characterization of the relationship between joint laxity and maternal hormones in pregnancy. Obstet Gynecol 101(2):331–335. https://doi.org/10.1016/s0029-7844(02)02447-xCrossRefPubMed

22.

Norton P, Baker J, Sharp H, Warenski J (1995) Genitourinary prolapse and joint hypermobility in women. Obstet Gynecol 85(2):225–228. https://doi.org/10.1016/0029-7844(94)00386-RCrossRefPubMed

23.

Callahan J (2014) Writing literature reviews: a reprise and update. Hum Resour Dev Rev 13(3):271–275. https://doi.org/10.1177/2F1534484314536705CrossRef

24.

Critical Appraisal Skills Programme (2018) CASP randomised controlled checklist. Available at: https://casp-uk.net/wp-content/uploads/2018/01/CASP-Randomised-Controlled-Trial-Checklist-2018.pdf [Accessed 13 March 2020]

25.

Critical Appraisal Skills Programme (2018) CASP cohort study checklist. Available at: https://casp-uk.net/wp-content/uploads/2018/01/CASP-Cohort-Study-Checklist_2018.pdf [Accessed 13 March 2020]

26.

Nadelson S, Nadelson L (2014) Evidence-based practice article reviews using CASP tools: a method for teaching EBP. Worldviews Evid-Based Nurs 11(5):344–346. https://doi.org/10.1111/wvn.12059CrossRefPubMed

27.

Bale P, Easton V, Bacon H, Jerman E, Watts L, Barton G, Clark A, Armon K, MacGregor A (2019) The effectiveness of a multidisciplinary intervention strategy for the treatment of symptomatic joint hypermobility in childhood: a randomised, single centre parallel group trial (the Bendy study). Pediatr Rheumatol Online J 17(2):1–10. https://doi.org/10.1186/s12969-018-0298-xCrossRef

28.

Bathen T, Hangmann AB, Hoff M, Anderson LO, Rand-Hendriksen S (2013) Multidisciplinary treatment of disability in Ehlers-Danlos syndrome hypermobility type/hypermobility syndrome: a pilot study using a combination of physical and cognitive-behavioral therapy on 12 women. Am J Med Genet A 161A(12):3005–3011. https://doi.org/10.1002/ajmg.a.36060CrossRefPubMed

29.

Celenay S, Kaya D (2017) Effects of spinal stabilization exercises in women with benign joint hypermobility syndrome: a randomized controlled trial. Rheumatol Int 37(9):1461–1468. https://doi.org/10.1007/s00296-017-3713-6CrossRef

30.

Daman M, Shiravani F, Hemmati L, Taghizadeh S (2019) The effect of combined exercise therapy on knee proprioception, pain intensity and quality of life in patients with hypermobility syndrome: a randomized clinical trial. J Bodyw Mov Ther 23(1):202–205. https://doi.org/10.1016/j.jbmt.2017.12.012CrossRefPubMed

31.

Ferrell W, Tennant N, Sturrock R, Ashton L, Creed G, Brydson G, Rafferty D (2004) Amelioration of symptoms by enhancement of proprioception in patients with joint hypermobility syndrome. Arthritis Rheum 50(10):3323–3328. https://doi.org/10.1002/art.20582CrossRefPubMed

32.

Kemp S, Roberts I, Gamble C, Wilkinson S, Davidson J, Baildam E, Cleary A, McCann L, Beresford M (2010) A randomized comparative trial of generalized vs targeted physiotherapy in the management of childhood hypermobility. Rheumatology (Oxford) 49(2):315–325. https://doi.org/10.1093/rheumatology/kep362CrossRef

33.

Pacey V, Tofts L, Adams R, Munns C, Nicholson L (2013) Exercise in children with joint hypermobility syndrome and knee pain: a randomised controlled trial comparing exercise into hypermobile versus neutral knee extension. Pediatr Rheumatol Online J 11(1):30. https://doi.org/10.1186/1546-0096-11-30CrossRefPubMedPubMedCentral

34.

Palmer S, Cramp F, Clark E, Lewis R, Brookes S, Hollingworth W, Welton N, Thom H, Terry R, Rimes KS, Horwood J (2016) The feasibility of a randomised controlled trial of physiotherapy for adults with joint hypermobility syndrome. Health Technol Assess 20(47):1–264. https://doi.org/10.3310/hta20470CrossRefPubMedPubMedCentral

35.

Reychler G, Liistro G, Piérard GE, Hermanns-Lê T, Manicourt D (2019) Inspiratory muscle strength training improves lung function in patients with the hypermobile Ehlers–Danlos syndrome: a randomized controlled trial. Am J Med Genet A 179A:356–364. https://doi.org/10.1002/ajmg.a.61016CrossRef

36.

Sahin N, Baskent A, Cakmak A, Salli A, Ugurlu H, Berker E (2008) Evaluation of knee proprioception and effects of proprioception exercise in patients with benign joint hypermobility syndrome. Rheumatol Int 28(10):995–1000. https://doi.org/10.1007/s00296-008-0566-zCrossRefPubMed

37.

To M, Alexander C (2018) Are people with joint hypermobility syndrome slow to strengthen? Arch Phys Med Rehabil 100(7):1243–1250. https://doi.org/10.1016/j.apmr.2018.11.021CrossRefPubMed

38.

Fives A, Russell D, Kearns N, Lyons R, Eaton P, Canavan J, Devaney C, O'Brien A (2013) The role of random allocation in randomized controlled trials: distinguishing selection bias from baseline imbalance. J Multidiscip Eval 9(20):33–42 http://journals.sfu.ca/jmde/index.php/jmde_1/article/view/371

39.

Akobeng A (2005) Understanding randomised controlled trials. Arch Dis Child 90(8):840–844. https://doi.org/10.1136/2Fadc.2004.058222CrossRefPubMedPubMedCentral

40.

Bland J, Altman D (2011) Comparisons against baseline within randomised groups are often used and can be highly misleading. Trials 12:264. https://doi.org/10.1186/1745-6215-12-264CrossRefPubMedPubMedCentral

41.

Song J, Chung K (2010) Observational studies: cohort and case-control studies. Plast Reconstr Surg 126(6):2234–2242. https://doi.org/10.1097/2FPRS.0b013e3181f44abcCrossRefPubMedPubMedCentral

42.

Boutron I, Guittet L, Estellat C, Moher D, Hrobjartsson A, Ravaud P (2007) Reporting methods of blinding in randomised controlled trials assessing non-pharmacological treatments. PLoS Med 4(2):e61. https://doi.org/10.1371/journal.pmed.0040061CrossRefPubMedPubMedCentral

43.

Hrobjartsson A, Emanuelsson F, Thomsen A, Hilden J, Brorson S (2014) Bias due to lack of patient blinding in clinical trials. A systematic review of trials randomizing patients to blind and nonblind sub-studies. Int J Epidemiol 43(4):1272–1283. https://doi.org/10.1093/ije/dyu115CrossRefPubMedPubMedCentral

44.

Skelly A, Dettori J, Brodt E (2012) Assessing bias: the importance of considering confounding. Evid Based Spine Care J 3(1):9–12. https://doi.org/10.1055/2Fs-0031-1298595CrossRefPubMedPubMedCentral

45.

Bookwala A, Hussain N, Bhandari M (2011) The three-minute appraisal of a prospective cohort study. Indian J Orthop 45(4):291–293. https://doi.org/10.4103/2F0019-5413.80315CrossRefPubMedPubMedCentral

46.

Garg R (2016) Methodology for research. Indian J Anaesth 60(9):640–645. https://doi.org/10.4103/2F0019-5049.190619CrossRefPubMedPubMedCentral

47.

Jager K, Zoccali C, MacLeod A, Dekker F (2008) Confounding: what it is and how to deal with it. Kidney Int 73(3):256–260. https://doi.org/10.1038/sj.ki.5002650CrossRefPubMed

48.

Elfil M, Negida A (2017) Sampling methods in clinical research: an educational review. Emerg (Tehran) 5(1):e52 https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5325924/

49.

Marshall M (1996) Sampling for qualitative research. Fam Pract 13(6):522–526. https://doi.org/10.1093/fampra/13.6.522CrossRefPubMed

50.

Fraser S, Spink K (2002) Examining the role of social support and group cohesion in exercise compliance. J Behav Med 25(3):233–249. https://doi.org/10.1023/a:1015328627304CrossRefPubMed

51.

Patino C, Ferreira J (2018) Inclusion and exclusion criteria in research studies: definitions and why they matter. J Bras Pnemol 44(2):84. https://doi.org/10.1590/2FS1806-37562018000000088CrossRef

52.

Rothwell P (2006) Factors that can affect the external validity of randomised controlled trials. PLOS Clin Trials 1(1):e9. https://doi.org/10.1371/2Fjournal.pctr.0010009CrossRefPubMedPubMedCentral

53.

Infante-Rivard C, Cusson A (2018) Reflection on modern methods: selection bias – a review of recent developments. Int J Epidemiol 47(5):1714–1722. https://doi.org/10.1093/ije/dyy138CrossRefPubMed

54.

Malfait F, Hakim A, de Paepe A, Grahame R (2006) The genetic basis of the joint hypermobility syndromes. Rheumatology (Oxford) 45(5):502–507. https://doi.org/10.1093/rheumatology/kei268CrossRef

55.

Jones S, Carley S, Harrison M (2003) An introduction to power and sample size estimation. Emerg Med J 20(5):453–458. https://doi.org/10.1136/2Femj.20.5.453CrossRefPubMedPubMedCentral

56.

Hickey G, Grant S, Dunning J, Siepe M (2018) Statistical primer: sample size and power calculations – why, when, and how? Eur J Cardiothorac Surg 54(1):4–9. https://doi.org/10.1093/2Fejcts%2Fezy169CrossRefPubMedPubMedCentral

57.

Nayak B (2010) Understanding the relevance of sample size calculation. Indian J Ophthalmol 58(6):469–470. https://doi.org/10.4103/2F0301-4738.71673CrossRefPubMedPubMedCentral

58.

Allmen R, Weiss S, Tevaearai H, Kuemmerli C, Tinner C, Carrel T, Schmidli J, Dick F (2015) Completeness of follow-up determines validity of study findings: results of a prospective repeated measures cohort study. PLoS One 10(10):e0140817. https://doi.org/10.1371/2Fjournal.pone.0140817CrossRef

59.

Ogunbayo O, Schafheutle E, Cutts C, Noyce P (2017) Self-care of long-term conditions: patients’ perspectives and their (limited) use of community pharmacies. Int J Clin Pharm 39(2):433–442. https://doi.org/10.1007/s11096-016-0418-yCrossRefPubMedPubMedCentral

60.

Barker I, Steventon A, Williamson R, Deeny S (2018) Self-management capability in patients with long-term conditions is associated with reduced healthcare utilisation across a whole health economy: cross-sectional analysis of electronic health records. BMJ Qual Saf 27(12):989–999. https://doi.org/10.1136/bmjqs-2017-007635CrossRefPubMedPubMedCentral

Title: The effectiveness of conservative interventions for the management of syndromic hypermobility: a systematic literature review
Authors: Shea Palmer
Indi Davey
Laura Oliver
Amara Preece
Laura Sowerby
Sophie House
Publication date: 01-03-2021
Publisher: Springer International Publishing
Keyword: Ehlers-Danlos Syndrome
Published in: Clinical Rheumatology / Issue 3/2021
Print ISSN: 0770-3198
Electronic ISSN: 1434-9949
DOI: https://doi.org/10.1007/s10067-020-05284-0

ACC 2024 Congress Coverage

Cardiology Video

Highlights from the ACC 2024 Congress

Watch now

Watch official videos from the ACC congress summarizing key highlights from the last year in heart failure, cardiomyopathies, valvular disease, pulmonary vascular disease, and pediatric cardiology.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits

ACC 2024 Pediatric and Congenital Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Pulmonary Vascular Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Valvular Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 HF and Cardiomyopathies: Year in Review/© 2024 American College of Cardiology, Woman out walking/© Seventyfour / stock.adobe.com (symbolic image with model), Woman checking smartwatch /© saltdium / stock.adobe.com (symbolic image with model), Cardiac catheterization/© Damian / stock.adobe.com

ACC 2024 Congress

Springer Medicine

Abstract

Introduction

Aim

Method

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 3/2021

Ultrasound measurement of muscle thickness at the anterior thigh level in rheumatology setting: a reliability study.

Anti-vinculin autoantibodies in systemic sclerosis: a step toward a novel biomarker?

Acknowledgement to Referees 2020

Sonozaki syndrome in the spotlight of imaging

TNFSF4 is a risk factor to systemic lupus erythematosus in a Latin American population

Fatigue and its correlates in Indian patients with systemic lupus erythematosus